Black Cohosh Menopause Meta-Analysis: 22 RCTs 2,310 Women Hot Flash Reduction
A natural option is becoming clearer for Korean women 50+ who cannot use hormone replacement therapy (HRT). 2023 meta-analysis showed black cohosh (Cimicifuga racemosa) meaningfully reduced hot flashes when 22 RCTs and 2,310 women were aggregated (Hedges g=0.315).
Meta-analysis core results
Participants: 22 RCTs 2,310 women aggregated. Perimenopause, postmenopause, late climacteric women.
Hot flash reduction: Hedges g=0.315 (meaningfully reduced vs placebo).
Night sweats: Consistent reduction.
Greene Climacteric Score: Meaningfully reduced.
Hormone effects: Estradiol, FSH, LH minimal change.
Duration: Effect assessment at 8~12 weeks.
Side effects: Generally minimal. Some GI discomfort, headache.
What is black cohosh
Black cohosh (Cimicifuga racemosa, Actaea racemosa): Eastern US native Ranunculaceae family plant.
Native use: Used by Native Americans for women’s health. Introduced to Europe in 17~18th centuries.
Active compounds: Triterpenoid glycosides (actein, 23-epi-26-deoxyactein), phenolic acids, flavonoids.
Standardized extract: Triterpenoid glycoside 4~7% standardization. Clinical data.
Modern use: Natural option for menopausal hot flashes. Increasingly recognized in Korea.
Mechanism
Non-hormone-mediated pathway:
- Initially presumed weak estrogenic action
- Currently proven non-hormone-mediated
- No estradiol, FSH, LH changes
Serotonin 5-HT pathway:
- 5-HT7 receptor partial agonist
- Acts on hot flash mechanism
Dopamine pathway some:
- Mood adjunct
Opioid pathway:
- Some data
Thermoregulatory center:
- Hypothalamic thermoregulation effects
- Hot flash reduction
Hormone-dependent tumor safe:
- Non-hormone-mediated, option for breast cancer, uterine fibroid patients
- However, physician consultation recommended
Who fits
Menopausal hot flashes + night sweats: Strongest data.
Hormone-dependent tumor patients: Patients unable to use HRT due to breast cancer, uterine fibroids.
HRT side effect complaints: Patients discontinued HRT due to bleeding, breast pain.
Mild~moderate menopause: First option.
With psychological symptoms: Anxiety, insomnia some adjunct.
Who should be careful
Liver injury reports: Rare but liver injury cases reported. Regular liver enzyme monitoring.
Pregnancy/breastfeeding: Avoid.
Uterine bleeding: After physician evaluation.
Drug interactions: Caution with some drugs. Consult physician.
GI sensitivity: Some have GI discomfort.
Allergy: Caution with Ranunculaceae allergies.
Dose and forms
Standardized extract: Triterpenoid glycoside 4~7% 40 mg/day.
General use: 20~80 mg/day.
Duration: Effect assessment at 8~12 weeks. 6 months~1 year use general.
Timing: With meals.
Form comparison
Standardized capsule (Remifemin etc.):
- Mainly clinical data this form
- Triterpenoid glycoside standardized
General extract:
- Not standardized
- Effect inconsistent
Liquid extract:
- Some use
Combination forms:
- Black cohosh + Vitex
- Black cohosh + St. John’s Wort (with depression)
- Black cohosh + DHEA (physician evaluation)
Other menopause options
Hormone replacement therapy (HRT):
- Strongest effect
- Physician evaluation
- Avoid hormone-dependent tumors
Isoflavones (soy):
- Weak estrogenic action
Maca (L16):
- Non-hormone-mediated - FAAH inhibition
- Sexual function + mood
DHEA:
- Adrenal hormone adjunct
Vitex (chasteberry):
- Prolactin modulation
Omega-3, vitamin D:
- General matrix
Black cohosh + maca + DHEA = non-hormone-mediated matrix.
Daily guide
Step 1 - Physician evaluation: Menopause stage, symptoms, hormone-dependent tumor assessment.
Step 2 - Dietary foundation: Soy, whole grains, exercise, sleep.
Step 3 - Supplement option: Black cohosh standardized 40 mg/day.
Step 4 - 8~12 week assessment: Hot flashes, night sweats, mood changes.
Step 5 - Matrix: Maca, Vitex, omega-3, vitamin D.
Step 6 - Monitoring: Regular liver enzyme tests. Bleeding caution.
Black cohosh is the non-hormone-mediated natural option for menopause. Natural matrix for hormone-concern patients. With physician evaluation.